vx-787
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01561807)
Timeline
Indications
Mechanism of action
- Influenza A virusINHIBITOR
Influenza A virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vx-787
- vx-787
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02342249 | Phase 2 | Dec 11, 2014 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT02262715 | Phase 1 | Jul 1, 2014 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT01561807 | Phase 2 | Mar 1, 2012 | Vertex |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Janssen Pharmaceutica NV | For profit | 2 | 0 | 2 | 2014 |
| Johnson and Johnson | For profit | 2 | 2 | 2 | 2014 |
| Vertex | For profit | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1